| 487 | Humans |
| 294 | Chloroquine |
| 239 | Animals |
| 219 | Female |
| 210 | Male |
| 150 | Lung |
| 128 | Lung Neoplasms |
| 125 | Autophagy |
| 119 | Mice |
| 101 | Cell Line, Tumor |
| 94 | Hydroxychloroquine |
| 92 | Adult |
| 83 | Middle Aged |
| 67 | Lung Diseases |
| 65 | Apoptosis |
| 62 | Antineoplastic Agents |
| 58 | Lung Diseases, Interstitial |
| 57 | Rats |
| 55 | Carcinoma, Non-Small-Cell Lung |
| 53 | Signal Transduction |
| 50 | Cell Survival |
| 50 | Aged |
| 49 | Cell Proliferation |
| 48 | Child |
| 47 | Treatment Outcome |
| 47 | Cells, Cultured |
| 47 | Antimalarials |
| 42 | Cell Line |
| 41 | Sarcoidosis |
| 35 | Immunosuppressive Agents |
| 33 | Mice, Inbred BALB C |
| 32 | Infant |
| 32 | Dose-Response Relationship, Drug |
| 31 | Microtubule-Associated Proteins |
| 31 | Liver |
| 31 | Antirheumatic Agents |
| 31 | Adolescent |
| 30 | Tomography, X-Ray Computed |
| 30 | Lysosomes |
| 29 | Drug Therapy, Combination |
| 28 | Adrenal Cortex Hormones |
| 27 | Xenograft Model Antitumor Assays |
| 27 | Time Factors |
| 27 | Plasmodium falciparum |
| 27 | Mice, Nude |
| 27 | A549 Cells |
| 26 | Retrospective Studies |
| 26 | Disease Models, Animal |
| 26 | Child, Preschool |
| 25 | Mutation |
| 25 | Drug Resistance, Neoplasm |
| 24 | TOR Serine-Threonine Kinases |
| 24 | Prednisolone |
| 24 | Fibroblasts |
| 24 | Drug Synergism |
| 23 | Lupus Erythematosus, Systemic |
| 23 | Kidney |
| 23 | Diagnosis, Differential |
| 22 | Radiography |
| 22 | Cyclophosphamide |
| 21 | Tumor Cells, Cultured |
| 21 | Mice, Inbred C57BL |
| 21 | Glucocorticoids |
| 21 | Gene Expression Regulation, Neoplastic |
| 21 | Follow-Up Studies |
| 21 | ErbB Receptors |
| 20 | Spleen |
| 20 | Prognosis |
| 20 | Phosphorylation |
| 20 | Biopsy |
| 20 | Anti-Inflammatory Agents |
| 19 | Prednisone |
| 19 | Hydrogen-Ion Concentration |
| 18 | Reactive Oxygen Species |
| 18 | Pulmonary Fibrosis |
| 18 | Proto-Oncogene Proteins c-akt |
| 18 | Malaria |
| 17 | Respiratory Function Tests |
| 17 | Protein Kinase Inhibitors |
| 17 | Methylprednisolone |
| 17 | Methotrexate |
| 16 | Myocardium |
| 16 | Infant, Newborn |
| 16 | Hemosiderosis |
| 16 | Arthritis, Rheumatoid |
| 16 | Anti-Bacterial Agents |
| 15 | RNA, Messenger |
| 15 | Enzyme Inhibitors |
| 15 | Beclin-1 |
| 15 | Azathioprine |
| 14 | Receptors, G-Protein-Coupled |
| 14 | Molecular Structure |
| 14 | In Vitro Techniques |
| 14 | Epithelial Cells |
| 14 | Brain |
| 14 | Antineoplastic Combined Chemotherapy Protocols |
| 13 | Sjogren's Syndrome |
| 13 | Rats, Sprague-Dawley |
| 13 | Plant Extracts |
| 13 | Macrophages |
| 13 | Lung Diseases, Parasitic |
| 13 | Drug Resistance |
| 13 | Blotting, Western |
| 13 | Antineoplastic Agents, Phytogenic |
| 12 | Structure-Activity Relationship |
| 12 | Skin |
| 12 | RNA, Small Interfering |
| 12 | Phospholipids |
| 12 | Liver Abscess, Amebic |
| 12 | Inflammation |
| 12 | Emetine |
| 12 | Chronic Disease |
| 12 | Bronchoalveolar Lavage Fluid |
| 12 | Asthma |
| 12 | Adenocarcinoma |
| 11 | Tissue Distribution |
| 11 | Phagosomes |
| 11 | Neoplasms |
| 11 | Neoplasm Metastasis |
| 11 | Kinetics |
| 11 | Hemorrhage |
| 11 | Cisplatin |
| 11 | Amebiasis |
| 10 | Tumor Necrosis Factor-alpha |
| 10 | Pulmonary Surfactant-Associated Protein C |
| 10 | Pulmonary Alveoli |
| 10 | Myocytes, Smooth Muscle |
| 10 | Muscle, Smooth |
| 10 | Membrane Proteins |
| 10 | Macrolides |
| 10 | Guinea Pigs |
| 10 | Gene Expression Regulation |
| 10 | Down-Regulation |
| 10 | DNA |
| 10 | Adenine |
| 9 | Young Adult |
| 9 | Virus Replication |
| 9 | Tumor Burden |
| 9 | Sirolimus |
| 9 | Rabbits |
| 9 | RNA Interference |
| 9 | Quinazolines |
| 9 | Piperazines |
| 9 | Membrane Potential, Mitochondrial |
| 9 | HeLa Cells |
| 9 | Drug Evaluation, Preclinical |
| 9 | Dermatomyositis |
| 9 | Cytokines |
| 9 | Cell Movement |
| 9 | Cell Cycle |
| 9 | Caspase 3 |
| 9 | Apoptosis Regulatory Proteins |
| 9 | Adenocarcinoma of Lung |
| 8 | Toll-Like Receptor 9 |
| 8 | Taste |
| 8 | Syndrome |
| 8 | Sarcoidosis, Pulmonary |
| 8 | Rats, Inbred Strains |
| 8 | Radiography, Thoracic |
| 8 | Quinolines |
| 8 | Pregnancy |
| 8 | Plasmodium |
| 8 | Peptides |
| 8 | Muscles |
| 8 | Muscle Relaxation |
| 8 | Mitochondria |
| 8 | Microscopy, Electron, Transmission |
| 8 | Indoles |
| 8 | Gene Knockdown Techniques |
| 8 | Gefitinib |
| 8 | Fatal Outcome |
| 8 | Drug Screening Assays, Antitumor |
| 8 | Disease Progression |
| 8 | Antibodies, Monoclonal |
| 7 | Tumor Suppressor Protein p53 |
| 7 | Transfection |
| 7 | Rituximab |
| 7 | Respiratory Distress Syndrome, Newborn |
| 7 | Quinine |
| 7 | Pulmonary Surfactants |
| 7 | Pulmonary Edema |
| 7 | Plasmids |
| 7 | Phosphatidylinositol 3-Kinases |
| 7 | Neoplasm Transplantation |
| 7 | Microscopy, Electron |
| 7 | Lung Abscess |
| 7 | Inhibitory Concentration 50 |
| 7 | Flow Cytometry |
| 7 | Erlotinib Hydrochloride |
| 7 | Endothelium, Vascular |
| 7 | Dyspnea |
| 7 | Drug Combinations |
| 7 | Case-Control Studies |
| 7 | Bronchodilator Agents |
| 7 | Arthritis |
| 7 | Antiviral Agents |
| 7 | Aged, 80 and over |
| 7 | Acute Disease |
| 7 | ATP-Binding Cassette Transporters |
| 6 | Vascular Resistance |
| 6 | Severity of Illness Index |
| 6 | Sequestosome-1 Protein |
| 6 | Scleroderma, Systemic |
| 6 | Recombinant Fusion Proteins |
| 6 | Rats, Wistar |
| 6 | Radionuclide Imaging |
| 6 | Pyrimidines |
| 6 | Pulmonary Artery |
| 6 | Proto-Oncogene Proteins c-bcl-2 |
| 6 | Phospholipases A |
| 6 | Penicillamine |
| 6 | Oxygen Inhalation Therapy |
| 6 | Organ Size |
| 6 | Neutrophils |
| 6 | Neoplasm Proteins |
| 6 | NF-kappa B |
| 6 | Microscopy, Fluorescence |
| 6 | Metronidazole |
| 6 | MAP Kinase Signaling System |
| 6 | Liver Abscess |
| 6 | Lipidoses |
| 6 | Iodine Radioisotopes |
| 6 | Incidence |
| 6 | Immunologic Factors |
| 6 | Immunohistochemistry |
| 6 | Heart |
| 6 | HCT116 Cells |
| 6 | Gene Transfer Techniques |
| 6 | Endothelial Cells |
| 6 | Dysentery, Amebic |
| 6 | Drug Administration Schedule |
| 6 | Dogs |
| 6 | Clinical Trials as Topic |
| 6 | Cholesterol |
| 6 | Cell Death |
| 6 | Calcium Signaling |
| 6 | Calcium Channel Blockers |
| 6 | Bronchi |
| 6 | Body Weight |
| 6 | Blood Pressure |
| 6 | Aspirin |
| 6 | Age Factors |
| 6 | Adaptor Proteins, Signal Transducing |
| 6 | Acute Lung Injury |
| 6 | AMP-Activated Protein Kinases |
| 5 | Up-Regulation |
| 5 | Trachea |
| 5 | Tandem Mass Spectrometry |
| 5 | Survival Analysis |
| 5 | Skin Diseases |
| 5 | Sex Factors |
| 5 | STAT3 Transcription Factor |
| 5 | Risk Factors |
| 5 | Risk Assessment |
| 5 | Reverse Transcriptase Polymerase Chain Reaction |
| 5 | Respiration, Artificial |
| 5 | Recurrence |
| 5 | Radiation Tolerance |
| 5 | Pyridines |
| 5 | Proteolysis |
| 5 | Protein Binding |
| 5 | Prevalence |
| 5 | Plants, Medicinal |
| 5 | Phospholipases |
| 5 | Phenotype |
| 5 | Mycophenolic Acid |
| 5 | Muscle Contraction |
| 5 | Models, Biological |
| 5 | Mice, Knockout |
| 5 | Melanoma |
| 5 | Malaria, Falciparum |
| 5 | Lymphangioleiomyomatosis |
| 5 | Liposomes |
| 5 | Lipopolysaccharides |
| 5 | Infliximab |
| 5 | Hydrocortisone |
| 5 | HEK293 Cells |
| 5 | Gene Expression |
| 5 | Eye |
| 5 | Escherichia coli |
| 5 | Enzyme-Linked Immunosorbent Assay |
| 5 | Entamoeba histolytica |
| 5 | Endoplasmic Reticulum Stress |
| 5 | Endocytosis |
| 5 | Drug Interactions |
| 5 | Dexamethasone |
| 5 | DNA Repair |
| 5 | DNA Damage |
| 5 | Carcinoma, Squamous Cell |
| 5 | Carcinoma, Small Cell |
| 5 | Biomarkers |
| 5 | Binding Sites |
| 5 | Autophagy-Related Protein 5 |
| 5 | Animals, Newborn |
| 5 | Administration, Inhalation |
| 4 | Vasculitis |
| 4 | Tuberculosis, Pulmonary |
| 4 | Triterpenes |
| 4 | Transforming Growth Factor beta |
| 4 | TNF-Related Apoptosis-Inducing Ligand |
| 4 | Swine |
| 4 | Survival Rate |
| 4 | Stomach |
| 4 | Serotonin |
| 4 | Respiratory System |
| 4 | Respiratory Mucosa |
| 4 | Respiratory Insufficiency |
| 4 | Recombinant Proteins |
| 4 | Randomized Controlled Trials as Topic |
| 4 | Quinacrine |
| 4 | Quercetin |
| 4 | Quaternary Ammonium Compounds |
| 4 | Pulmonary Alveolar Proteinosis |
| 4 | Protein Processing, Post-Translational |
| 4 | Prostaglandins |
| 4 | Pneumonia |
| 4 | Pleurisy |
| 4 | Plant Bark |
| 4 | Phospholipases A2 |
| 4 | Phosphoinositide-3 Kinase Inhibitors |
| 4 | Phenanthrenes |
| 4 | Permeability |
| 4 | Parasitic Sensitivity Tests |
| 4 | Pancreatic Neoplasms |
| 4 | Oncogene Protein v-akt |
| 4 | Oligodeoxyribonucleotides |
| 4 | Neoplastic Stem Cells |
| 4 | Monensin |
| 4 | Molecular Weight |
| 4 | Mice, Inbred DBA |
| 4 | Membrane Glycoproteins |
| 4 | Magnetic Resonance Imaging |
| 4 | Lymph Nodes |
| 4 | Ligands |
| 4 | Interleukin-8 |
| 4 | Injections, Intravenous |
| 4 | Infusions, Intravenous |
| 4 | Indomethacin |
| 4 | India |
| 4 | Immunoblotting |
| 4 | Imidazoles |
| 4 | Hypertension, Pulmonary |
| 4 | Hypercalcemia |
| 4 | Histamine |
| 4 | Green Fluorescent Proteins |
| 4 | Glycoproteins |
| 4 | Genetic Vectors |
| 4 | Ganoderma |
| 4 | Fungal Proteins |
| 4 | Fetal Organ Maturity |
| 4 | Extracellular Signal-Regulated MAP Kinases |
| 4 | Etoposide |
| 4 | Erythrocytes |
| 4 | Enzyme Activation |
| 4 | Drug Carriers |
| 4 | Doxycycline |
| 4 | DNA, Bacterial |
| 4 | Culture Media, Conditioned |
| 4 | Cross-Sectional Studies |
| 4 | Cricetulus |
| 4 | Cricetinae |
| 4 | Combined Modality Therapy |
| 4 | Colonic Neoplasms |
| 4 | Collagen |
| 4 | Chromatography, High Pressure Liquid |
| 4 | Cholesterol Esters |
| 4 | Chick Embryo |
| 4 | Cell Membrane |
| 4 | Cell Hypoxia |
| 4 | Cell Division |
| 4 | Cell Cycle Checkpoints |
| 4 | Caspases |
| 4 | Cardiac Output |
| 4 | Bronchoscopy |
| 4 | Bronchoalveolar Lavage |
| 4 | Blood |
| 4 | Azithromycin |
| 4 | Autoimmune Diseases |
| 4 | Arthritis, Juvenile |
| 4 | Antibodies, Antinuclear |
| 4 | Anti-Inflammatory Agents, Non-Steroidal |
| 4 | Aniline Compounds |
| 4 | Ammonium Chloride |
| 4 | Aminoquinolines |
| 4 | Amines |
| 4 | Adrenergic beta-Agonists |
| 4 | Adrenal Glands |
| 4 | Administration, Oral |
| 4 | Adenosine Triphosphate |
| 4 | Acrylamides |
| 3 | src-Family Kinases |
| 3 | p38 Mitogen-Activated Protein Kinases |
| 3 | Vitamin E |
| 3 | Vacuoles |
| 3 | Urinary Bladder Neoplasms |
| 3 | Tumor Microenvironment |
| 3 | Transforming Growth Factor beta1 |
| 3 | Toxicology |
| 3 | Toll-Like Receptor 4 |
| 3 | Toll-Like Receptor 3 |
| 3 | Tetracycline |
| 3 | Surveys and Questionnaires |
| 3 | Stereoisomerism |
| 3 | Spectrophotometry |
| 3 | Species Specificity |
| 3 | Siblings |
| 3 | SRS-A |
| 3 | Rheumatoid Factor |
| 3 | Respiratory Distress Syndrome, Adult |
| 3 | Research |
| 3 | Reproducibility of Results |
| 3 | Reperfusion Injury |
| 3 | Remission Induction |
| 3 | Receptors, Cell Surface |
| 3 | Raynaud Disease |
| 3 | Radiation-Sensitizing Agents |
| 3 | Pyrazoles |
| 3 | Pyrazines |
| 3 | Pseudomonas aeruginosa |
| 3 | Propranolol |
| 3 | Primaquine |
| 3 | Poly(ADP-ribose) Polymerases |
| 3 | Poly I-C |
| 3 | Pneumonia, Bacterial |
| 3 | Pleural Effusion |
| 3 | Plasmodium vivax |
| 3 | Plasmodium berghei |
| 3 | Plasmapheresis |
| 3 | Phosphatidylethanolamines |
| 3 | Pharmacology |
| 3 | Pharmaceutical Preparations |
| 3 | Peptidyl-Dipeptidase A |
| 3 | Paclitaxel |
| 3 | Oxyphenbutazone |
| 3 | Oxidative Stress |
| 3 | Opportunistic Infections |
| 3 | Oligonucleotides |
| 3 | Off-Label Use |
| 3 | Nuclear Proteins |
| 3 | Norepinephrine |
| 3 | Nanoparticles |
| 3 | Mutation, Missense |
| 3 | Muscle, Skeletal |
| 3 | Morpholines |
| 3 | Molecular Targeted Therapy |
| 3 | Mitogen-Activated Protein Kinase 3 |
| 3 | Microscopy, Confocal |
| 3 | Microbial Sensitivity Tests |
| 3 | MicroRNAs |
| 3 | Mice, Inbred Strains |
| 3 | Methanol |
| 3 | Metabolic Syndrome |
| 3 | Mesothelioma |
| 3 | Macrophages, Alveolar |
| 3 | MCF-7 Cells |
| 3 | Lymphocyte Activation |
| 3 | Lung Volume Measurements |
| 3 | Lung Compliance |
| 3 | Longitudinal Studies |
| 3 | Liver Neoplasms |
| 3 | Liver Function Tests |
| 3 | Lipoproteins, LDL |
| 3 | Leupeptins |
| 3 | Leukopenia |
| 3 | Leukocytes, Mononuclear |
| 3 | Leukemia L1210 |
| 3 | Large-Conductance Calcium-Activated Potassium Channels |
| 3 | Janus Kinase 2 |
| 3 | Intracellular Membranes |
| 3 | Intestines |
| 3 | Interleukin-6 |
| 3 | Interleukin-1beta |
| 3 | Intercellular Adhesion Molecule-1 |
| 3 | Intercalating Agents |
| 3 | Immunotherapy |
| 3 | Immunoglobulins, Intravenous |
| 3 | Imipramine |
| 3 | Hypoxia |
| 3 | Hypoxia-Inducible Factor 1, alpha Subunit |
| 3 | Host-Pathogen Interactions |
| 3 | Homozygote |
| 3 | Granuloma |
| 3 | Forced Expiratory Volume |
| 3 | Fluorescent Antibody Technique |
| 3 | Fluorescence |
| 3 | Epidermal Growth Factor |
| 3 | Endotoxins |
| 3 | Empyema |
| 3 | Electrocardiography |
| 3 | Drugs, Chinese Herbal |
| 3 | Drug Resistance, Microbial |
| 3 | Drug Design |
| 3 | Doxorubicin |
| 3 | Diphtheria Toxin |
| 3 | Diagnostic Imaging |
| 3 | DNA, Viral |
| 3 | DNA, Neoplasm |
| 3 | DNA Topoisomerases, Type II |
| 3 | DNA Mutational Analysis |
| 3 | Cytotoxins |
